ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Aj Bell Plc

Aj Bell Plc (AJB)

445.00
-4.50
(-1.00%)
Cerrado 05 Enero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
445.00
Postura de Compra
445.00
Postura de Venta
445.50
Volume Operado de la Acción
406,140
445.00 Rango del Día 448.50
281.00 Rango de 52 semanas 518.00
Capitalización de Mercado [m]
Precio Anterior
449.50
Precio de Apertura
448.50
Última hora de negociación
Volumen financiero
1,808,403p
Precio Promedio Ponderado
445.2658
Volumen promedio (3 m)
963,057
Acciones en circulación
413,044,826
Rendimiento del Dividendo
2.81%
Ratio Precio/Utilidad
21.80
Beneficio por acción (BPA)
0.2
turnover
269.44M
Beneficio neto
84.3M

Acerca de Aj Bell Plc

Sector
Investment Advice
Industria
Investment Advice
Sitio web
Sede
Manchester, Gbr
Fundado
-
Aj Bell Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker AJB. The last closing price for Aj Bell was 449.50p. Over the last year, Aj Bell shares have traded in a share price range of 281.00p to 518.00p.

Aj Bell currently has 413,044,826 shares in issue. The market capitalisation of Aj Bell is £1.86 billion. Aj Bell has a price to earnings ratio (PE ratio) of 21.80.

AJB Últimas noticias

AJ Bell PLC Total Voting Rights

AJ Bell PLC 27 December 2024   AJ Bell plc ("AJ Bell" or the "Company") Total Voting Rights In accordance with rule 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, the Company...

DIRECTOR DEALINGS: Bank of Georgia exec, AJ Bell CFO, Yu director sell

The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and ...

AJ Bell PLC Block listing Interim Review

AJ Bell PLC 20 December 2024   BLOCK LISTING SIX MONTHLY RETURN   (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 20 December 2024   Name of applicant: AJ...

AJ Bell PLC Director/PDMR Shareholding

AJ Bell PLC 19 December 2024   AJ Bell plc ("AJ Bell" or the "Company") Director/PDMR Transactions - Initial Notification   The Company announces that Peter Birch, the Chief Financial Officer...

AJ Bell PLC Director/PDMR Shareholding

AJ Bell PLC 18 December 2024   AJ Bell plc ("AJ Bell" or the "Company") Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...

AJ Bell PLC Total Voting Rights

AJ Bell PLC 17 December 2024   AJ Bell plc ("AJ Bell" or the "Company") Issue of Ordinary Shares and Total Voting Rights   On 17 December 2024, the Company issued 50,509 new ordinary shares of...

AJ Bell PLC Transaction in Own Shares

AJ Bell PLC 17 December 2024   17 December 2024 AJ Bell plc Transaction in Own Shares   AJ Bell plc ("Company") announces that it has purchased the following number of its ordinary shares of...

AJ Bell PLC Transaction in Own Shares

AJ Bell PLC 16 December 2024   16 December 2024 AJ Bell plc Transaction in Own Shares   AJ Bell plc ("Company") announces that it has purchased the following number of its ordinary shares of...

AJ Bell PLC Notice of AGM

AJ Bell PLC 13 December 2024   13 December 2024 AJ Bell plc ("AJ Bell" or the "Company") Publication of Annual Report and Notice of Annual General Meeting AJ Bell has today posted the Annual...

AJ Bell PLC Transaction in Own Shares

AJ Bell PLC 13 December 2024   13 December 2024 AJ Bell plc Transaction in Own Shares   AJ Bell plc ("Company") announces that it has purchased the following number of its ordinary shares of...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-13.5-2.94438386041458.5475445231568450.68970001DE
4-24-5.11727078891469496431.51001711466.28812406DE
12-0.5-0.112233445567445.5518430963057466.64246408DE
268222.5895316804363518363830874451.39112243DE
5216156.6901408451284518281811592395.49417579DE
15655.214.1611082606389.8518242.8825246337.09482374DE
260173.97196261682428518229887445367.05116158DE

AJB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aj Bell?
El precio actual de las acciones de Aj Bell es 445.00p
¿Cuántas acciones de Aj Bell están en circulación?
Aj Bell tiene 413,044,826 acciones en circulación
¿Cuál es la capitalización de mercado de Aj Bell?
La capitalización de mercado de Aj Bell es GBP 1.86B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aj Bell?
Aj Bell ha negociado en un rango de 281.00p a 518.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Aj Bell?
El ratio precio/beneficio de Aj Bell es 21.8
¿Cuál es el ratio de efectivo a ventas de Aj Bell?
El ratio de efectivo a ventas de Aj Bell es 6.82
¿Cuál es la moneda de reporte de Aj Bell?
Aj Bell presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Aj Bell?
El último ingresos anual de Aj Bell es GBP 269.44M
¿Cuál es el último beneficio anual de Aj Bell?
El último beneficio anual de Aj Bell es GBP 84.3M
¿Cuál es la dirección registrada de Aj Bell?
La dirección registrada de Aj Bell es 4 EXCHANGE QUAY, SALFORD QUAYS, MANCHESTER, M5 3EE
¿Cuál es la dirección del sitio web de Aj Bell?
La dirección del sitio web de Aj Bell es www.ajbell.co.uk
¿En qué sector industrial opera Aj Bell?
Aj Bell opera en el sector INVESTMENT ADVICE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
sand sand 4 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 4 minutos hace
Moving hard soon 
EFSH
mining101 mining101 5 minutos hace
Superb
MEGL
benz280c benz280c 12 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 19 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 20 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 23 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 29 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 29 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 34 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 36 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 37 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 39 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 42 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 45 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 46 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 47 minutos hace
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 48 minutos hace
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 49 minutos hace
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 1 hora hace
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 1 hora hace
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 1 hora hace
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 1 hora hace
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX